How to Cite
×
Home
About
Aims and Scope
Editorial Board
Advisory Board
Guidelines for Authors
Contact
Current Issue
Early View
Archive
Asthma Allergy Immunology
22 Record Found
A Rare Presentation of Coeliac Disease; Intractable Itching with Recurrent Heart Attack and Dermatitis Herpetiformis
Sumeyra ALAN YALIM, Betül DUMANOĞLU, Merve POYRAZ, Gulistan ALPAGAT, Ayse BAÇÇIOĞLU, Ayse Fusun KALPAKLIOĞLU
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature
Andac SALMAN, Meryem AKTAŞ
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Pros and Cons of Nebulizer Treatment in Asthma Exacerbation During the COVID-19 Pandemic
Ayşe Bilge ÖZTÜRK, Ayşe BACCIOĞLU, Özge UYSAL SOYER, Ersoy CIVELEK, Bülent Enis ŞEKEREL, Sevim BAVBEK
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Association of Cold Urticaria with Aquagenic Urticaria in an Adolescent Girl: A Case Report
Mehmet KILIÇ, Erdal TAŞKIN, Mahir TAN, Alp GÖZÜTOK
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Asthma as a Comorbid Disease in COVID-19
Ayşe BAÇÇIOĞLU, Sevim BAVBEK
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Role of SARS-CoV-2 in Asthma Exacerbations
Ayşe Bilge ÖZTÜRK, Sevim BAVBEK
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
COVID-19 Disease and Hereditary Angioedema
Aycan AŞIK, Nihal METE GÖKMEN
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
SARS-CoV-2 in a Patient with Persistent Asthma Taking Omalizumab: The First Case in Turkey
Emel ATAYIK, Gökhan AYTEKİN
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Mortality due to COVID-19 in a Patient with Severe Asthma Receiving Omalizumab Treatment: A Case Report
Mehmet Erdem ÇAKMAK, Saltuk Buğra KAYA, Özge Can BOSTAN, Gülseren TUNCAY, Ebru DAMADOĞLU, Gül KARAKAYA, Ali Fuat KALYONCU
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Allergic Bronchopulmonary Aspergillosis: A Clinical Evaluation of 15 Patients and Successful Omalizumab Treatment of Five Patients
Derya ÜNAL
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria
Duru TABANLIOĞLU-ONAN, Ayşe ÖKTEM, Başak YALÇIN, Ferda ARTÜZ
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study
Sakine NAZİK BAHÇECİOĞLU, Murat TÜRK, Emel ATAYIK, Gülden PAÇACI ÇETİN, Bahar ARSLAN, İnci GÜLMEZ, İnsu YILMAZ
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Low Counts of Eosinophils After the 4th Dose of Mepolizumab May be an Independent Risk Factor for Sars-CoV-2 Transmission in Patients with Severe Asthma
Emel ATAYIK, Gökhan AYTEKIN
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Efficacy of Omalizumab Treatment in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap (ACO)
Dane EDIGER, Müge ERBAY, Ümmühan ŞEKER
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Hyperamylasemia During Omalizumab Therapy
Esra KARABİBER, Özge ÖZTÜRK AKTAŞ, Ebru ÖZDEMIR, Ebru DAMADOĞLU, Ümit Murat ŞAHINER, Gül KARAKAYA, Ali Fuat KALYONCU
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Omalizumab in Practice: Ten-Year Experience of A Tertiary Referral Allergy Centre
Nida ÖZTOP, Semra DEMIR, Şengül BEYAZ, Özdemir Can TÜZER, Bahauddin ÇOLAKOĞLU, Suna BÜYÜKÖZTÜRK, Aslı GELINCIK
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
The Impact of Vaccination with SARS-CoV-2 Vaccines on the Course of Chronic Spontaneous Urticaria
Sengul BEYAZ, Neyran SERBETCI, Zeynep Turkan FENDOGLU, Esra Nur BULBUL, Zeynep HANCIOGLU, Dilek OKSUZER CIMSIR, Ozge OZTURK AKTAS, Zeynep CELEBI SOZENER, Sadan SOYYIGIT
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
The Frequency and Severity of COVID-19 in Patients Receiving Biological Agents and Risk Factors: Experience of an Allergy Clinic
Sadan SOYYIGIT, Sengul BEYAZ, Zeynep CELEBI SOZENER
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Chronic Spontaneous Urticaria Patient Developing Idiopathic Anaphylaxis and Responding to Omalizumab Treatment: Case Report
Oner OZDEMIR, Ummugulsum DIKICI, Busra Sultan KIBAR
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Allergic Bronchopulmonary Aspergillosis Treated with Mepolizumab and Omalizumab: Switching Biological Agents
Zeynep YEGIN KATRAN, Ismet BULUT
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
Spontaneous Pneumomediastinum in a Patient with Allergic Bronchopulmonary Mycosis
Kasım OKAN, Meryem DEMIR, Hatice Serpil AKTEN, Ozlem GOKSEL
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite
A Current Overview of Latex Allergy
Feridun GURLEK
Abstract
Full Text:PDF
Recommended articles
Mail to Author
How to Cite